Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2000
11/30/2000WO2000040700A3 Oocyte activation by sperm components
11/30/2000WO2000040694A3 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants
11/30/2000WO2000034481A3 DRUG TARGETS IN $i(CANDIDA ALBICANS)
11/30/2000WO2000032772A9 Erythropoietic compounds
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000026380A9 Rotavirus subunit vaccine
11/30/2000WO2000025725A3 Functional antagonists of hedgehog activity
11/30/2000WO2000009658A8 Gene regulating circadian clock function and photoperiodism
11/30/2000DE19924342A1 Genetisch modifizierte Pflanzenzellen und Pflanzen mit erhöhter Aktivität eines Amylosucraseproteins und eines Verzweigungsenzyms Genetically modified plant cells and plants with an increased activity of an amylosucrase and a branching enzyme
11/30/2000DE19919625A1 In vitro production of heart valve by providing carrier with fibroblasts and/or myofibroblasts and then endothelial cells, followed by treatment in pulsating flow chamber of bioreactor
11/30/2000CA2382774A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000CA2375032A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374608A1 Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid
11/30/2000CA2374532A1 Recombinant bacterial phytases and uses thereof
11/30/2000CA2374517A1 Inducible packaging cell lines for lentivirus vectors
11/30/2000CA2374507A1 Assay for the detection of paclitaxel resistant cells in human tumors
11/30/2000CA2374476A1 Interaction-activated proteins
11/30/2000CA2374432A1 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000CA2374416A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses
11/30/2000CA2374413A1 Human oxidoreductase proteins
11/30/2000CA2374354A1 Immunogenic peptides derived from mage and the use thereof
11/30/2000CA2374301A1 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000CA2374070A1 Tagged epitope protein transposable element
11/30/2000CA2374021A1 Methods for regulating protein conformation using molecular chaperones
11/30/2000CA2374019A1 Models of prion disease
11/30/2000CA2373751A1 Isoflavonoid methylation enzyme
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373372A1 Novel phytochelatin synthases and uses therefor
11/30/2000CA2373221A1 Human antibodies to staphylococcus aureus
11/30/2000CA2371828A1 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000CA2371659A1 Method for enhancing cellulose and modifying lignin biosynthesis in plants
11/30/2000CA2371500A1 Expression products of genes involved in diseases related to cholesterol metabolism
11/29/2000EP1055684A1 Tumor antigen peptide derivatives
11/29/2000EP1055366A1 Use of transgenic mice lacking jun-b expression in the myeloid lineage
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054991A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
11/29/2000EP1054989A1 Methods for pseudoadenoviral vector production
11/29/2000EP1054986A1 Isolated and purified nucleic acids comprising a gene specifically expressed in hop glands
11/29/2000EP1054982A2 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides
11/29/2000EP1054981A2 Prostate-associated serine protease
11/29/2000EP1054980A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA
11/29/2000EP1054979A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
11/29/2000EP1054977A1 Method for producing biotin
11/29/2000EP1054975A1 Splice variants of p101 protein
11/29/2000EP1054972A2 Insecticidal toxins from photorhabdus
11/29/2000EP1054970A1 Pollen specific promoter
11/29/2000EP1054969A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
11/29/2000EP1054967A1 Connective tissue growth factor homologs
11/29/2000EP1054966A1 Ammaid, a g protein coupled receptor
11/29/2000EP1054965A2 Members of the d52 gene family
11/29/2000EP1054964A1 Members of the d52 gene family
11/29/2000EP1054963A1 Sequences of an ih ionic channel and the use thereof
11/29/2000EP1054962A2 Caf1-related protein
11/29/2000EP1054961A2 Human short-chain tnf-receptor family protein
11/29/2000EP1054958A1 Human serine protease and serpin polypeptides
11/29/2000EP1054954A1 Development of regulatory cells as a means for treating autoimmune disease
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054903A1 Fishboy, a g-protein coupled receptor
11/29/2000EP1054693A1 Inhibitors of complement activation
11/29/2000EP1054687A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
11/29/2000EP1054684A1 Method of promoting neuronal cell proliferation and differentiation
11/29/2000EP1054683A1 Modified heat shock protein-antigenic peptide complex
11/29/2000EP1054664A1 Method for modulating macrophage activation
11/29/2000EP1054591A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
11/29/2000EP0991770B1 Prostate cancer gene
11/29/2000EP0862453A4 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis
11/29/2000EP0749323B1 Methods for modulating t cell anergy
11/29/2000EP0636181B1 Use of a gene encoding oxalate oxidase for the transformation of plants
11/29/2000EP0585419B1 Method and apparatus for growing biomass particles
11/29/2000EP0555205B1 Dna encoding a growth factor specific for epithelial cells
11/29/2000CN1275162A Death domain containing receptor 5
11/29/2000CN1275161A Monoclonal antibody 3-6-A specific to surface of dendritic cells among the peripheral blood leukocytes
11/29/2000CN1275085A Cytolysis of target cell, reagent and composition for cytolysis and compound for preparing these reagents
11/29/2000CN1275084A Recombinant porcine adenovirus vector
11/29/2000CN1275050A Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
11/29/2000CN1274753A Nucleus autotransplanting technology
11/29/2000CN1274752A Cell retaining and separating method and device for cell depositing culture
11/29/2000CN1058991C Hematopoietic facilitatory cells
11/28/2000US6153739 Polynucleotides encoding human uridine diphosphate galactose-4-epimerase
11/28/2000US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies
11/28/2000US6153593 Laminin 5 and the formation of basement membrane structure
11/28/2000US6153582 Defined serumfree medical solution for ophthalmology
11/28/2000US6153435 Nucleotide sequences coding hybrid envelope polypetides; for gene therapy
11/28/2000US6153432 Incubating isolated human preadipocytes, plated at least about 25,000 cells/cm2, in a medium containing glucose, a cyclic amp inducer such as isobutylmethylxanthine or forskolin, a glucocorticoid or insulin
11/28/2000US6153430 Used as indicator of the presence of ovarian cancer tumor cells
11/28/2000US6153429 Cell lines useful for in vitro assay for indentification of carcinogens
11/28/2000US6153417 CSAPK-1 protein and uses therefor
11/28/2000US6153402 Death domain containing receptors
11/28/2000US6153380 In vitro mehtod by introducing library of random nucleic acids into cells to produce peptides, screening for cells exhibiting an altered phenotype; better intracellular localization of peptides
11/28/2000US6153373 Method for sex determination of mammalian offspring
11/28/2000US6153292 Biopolymer foams for use in tissue repair and reconstruction
11/28/2000US6153201 Oral immunization with papillomavirus virus-like particles
11/28/2000US6153192 An amino acid sequence consisting of at least 6 contiguous amino acids and no more than 39 contiguous amino acids found at positions 144-183 of human microglobulin; for use in immunoassay to determine human microglobulin in a sample
11/28/2000US6153190 Monoclonal antibodies which are receptor agonists; use as the immunizing antigen
11/28/2000US6153188 A recombinant human iduronate 2-sulfatase (ids) which is highly glycosylated than the naturally occurring enzyme isolated from human tissue and wherein recombinant iduronate 2-sulfatase is produced in chinese hamster overy cells
11/28/2000US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor
11/28/2000US6152964 Method for in vitro production of bone
11/28/2000CA2307470A1 Viral/insect gene that disrupts insect metamorphosis
11/28/2000CA2307357A1 Wbpp and method for assay of wbpp
1 ... 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 ... 1827